SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is experiencing a period of heightened volume and volatility as investors react to a significant new partnership with Jazz Pharmaceuticals and look ahead to critical clinical readouts later this year. The stock is currently a major focus of community debate, with bulls highlighting the long-term potential of the company's AI-driven drug discovery platform, while bears remain focused on historical underperformance and the risks inherent in upcoming trial data.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx shares are currently experiencing volatility as investors weigh strong IBSRELA revenue growth against the ongoing uncertainty surrounding a CMS court ruling and management's aggressive spending strategy. While the community is debating potential M&A rumors and the long-term impact of pending legal outcomes, active traders are closely monitoring institutional volume and support levels while awaiting a definitive catalyst to break the current consolidation pattern.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is trending as investors rotate into defensive, income-focused positions amid broader market uncertainty. Community discourse centers on the ETF's role as a stable portfolio anchor for long-term compounding, with active discussions regarding dividend growth consistency, reconstitution updates, and strategic buying opportunities.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to reports of a Japanese government delegation planning to explore rare-earth mining opportunities in Greenland, a region where the company controls a major stake in the Tanbreez Project. Community discussion is heavily focused on potential geopolitical tailwinds, the company's progress toward production, and active debates over the stock's valuation, share dilution, and the timing of upcoming project updates.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is facing significant downward pressure following the release of incomplete May sales data, which has exacerbated investor concerns and fueled speculation regarding competitive threats from AstraZeneca's Ultomiris. Despite the negative price action, the community is actively debating the reliability of these sales metrics and looking toward upcoming regulatory milestones, including EMA developments and the activation of the J-Code, as potential catalysts for a recovery.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors focus on its inclusion in the Russell 2000 and the potential for a share price surge driven by passive inflows and high short interest. Community discussion remains heavily polarized between bulls anticipating a strategic buyout based on the AXPAXLI clinical data and bears betting against the company's reliance on a single pivotal trial for regulatory approval.

Comcast Corp. engages in the provision of video, Internet, and phone services. It operates through the following segments: Residential Connectivity and Platforms, Business Services Connectivity, Media, Studios, and Theme Parks. The Residential Connectivity and Platforms segment consists of residential broadband and wireless services and Sky-branded entertainment television networks and advertising. The Business Service Connectivity segment offers broadband, wireline voice and wireless services through small to medium customers and large enterprises through the HFC network. The Media segment consists of NBCUniversal’s television and streaming platforms, including national, regional, and international cable networks. The Studios segment focuses on NBCUniversal’s film and television studio production and distribution operations. The Theme Parks segment operates Universal theme parks in Orlando, Florida, Hollywood, California, Osaka, Japan, and Beijing, China. The company was founded by Ralph Roberts in 1963 and is headquartered in Philadelphia, PA.

Comcast Corp - Ordinary Shares - Class A

Comcast Corp

Comcast is currently trending as a heavily debated value play, with shareholders balancing frustration over stagnant price action and broadband subscriber losses against optimism regarding the company's strong free cash flow, ongoing share buybacks, and profitable growth potential in its theme parks and media divisions. Investors are closely monitoring the upcoming ex-dividend date while discussing the potential for a rebound driven by a low valuation relative to peers.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors weigh aggressive government backing, including major CHIPS Act funding and site selection for a massive magnet manufacturing facility, against volatility from the broader rare earth sector and an ongoing legal dispute with MP Materials. Community members are actively debating whether these fundamental tailwinds and defense-critical supply chain integration represent a long-term structural breakout or a high-beta cyclical trade.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology remains at the center of investor focus as the market closely monitors the sustainability of the AI-driven storage supercycle and the company's ability to maintain high pricing power amidst structural supply constraints. While some community members are betting on continued long-term growth and supply bottlenecks, others are actively debating whether the current valuations have become overheated or if the sector's pivot toward critical data infrastructure justifies further upside.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver Corporation is attracting significant community attention as investors debate the impact of recent permit developments at Santa Elena against a backdrop of ongoing silver price volatility and broader market uncertainty. While some traders express frustration over disconnected stock performance and manipulation concerns, others remain focused on the long-term fundamentals, citing record production, liquidity, and potential supply deficits as catalysts for a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CorVel Stock Is Down 45%, But This Fund Just Made a $20 Million Move

Key PointsOwls Nest acquired 348,329 shares of CorVel last quarter; the estimated trade size was $20.06 million (based on quarterly average prices...

CorVel (CRVL) Q4 2026 Earnings Call Transcript

CorVel (CRVL) Q4 2026 Earnings Call Transcript...

CorVel Corp. Q4 Profit Climbs

(RTTNews) - CorVel Corp. (CRVL) released earnings for its fourth quarter that Increased, from the same period last year...

M&T Bank Corp Increases Stock Holdings in CorVel Corp. $CRVL

M&T Bank Corp lifted its position in shares of CorVel Corp. (NASDAQ:CRVL - Free Report) by 1,230.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 63,439 shares of the business services provider's stock after buying an additiona...

Boston Trust Walden Corp Has $33.44 Million Stock Position in CorVel Corp. $CRVL

Boston Trust Walden Corp decreased its position in CorVel Corp. (NASDAQ:CRVL - Free Report) by 6.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 494,152 shares of the business services provider's stock after selling 34,930 sha...

CorVel (NASDAQ:CRVL) Share Price Crosses Below 200-Day Moving Average   - What's Next?

CorVel (NASDAQ:CRVL) Shares Pass Below 200 Day Moving Average - Here's Why...

CorVel Insider Sale of $130K Comes Amid 50% One-Year Stock Drop. Here's What Investors Should Know

Key PointsThe chief information officer of Cervel reported selling 2,400 shares for a total of $130,000, based on a weighted average price of $54.00 per share on March 16, 2026...

Argent Capital Management LLC Takes $1.80 Million Position in CorVel Corp. $CRVL

Argent Capital Management LLC purchased a new position in CorVel Corp. (NASDAQ:CRVL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Maxim Shishin Sells 2,400 Shares of CorVel (NASDAQ:CRVL) Stock

CorVel Corp. (NASDAQ:CRVL - Get Free Report) insider Maxim Shishin sold 2,400 shares of the business's stock in a transaction on Monday, March 16th. The stock was sold at an average price of $54.00...

CorVel (NASDAQ:CRVL) Insider Sells $129,600.00 in Stock

CorVel Corp. (NASDAQ:CRVL - Get Free Report) insider Maxim Shishin sold 2,400 shares of the business's stock in a transaction dated Monday, March 16th. The shares were sold at an average price of...

CorVel Corp. engages in the provision of services to employers and payors in the risk management and insurance services arenas, including workers' compensation, general liability, auto liability, and hospital bill auditing and payment integrity. It operates through the Patient Management Services and Network Solutions Services segments. The Patient Management Services segment includes claims administration, utilization review, medical case management, and vocational rehabilitation. The Network Solutions Services segment consists of fee schedule auditing, hospital bill auditing, coordination of independent medical examinations, diagnostic imaging review services, and preferred provider referral services. The company was founded by V. Clemons Gordon Sr. in 1987 and is headquartered in Fort Worth, TX.

Corvel Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRVLCorvel Corp.

Fundamentals

Latest CRVL News